title: Dysphagia in Parkinson's disease is responsive to levodopa.
abstract: The role of levodopa in the treatment of dysphagia in Parkinson's disease (PD) has recently been questioned. There are good reasons, however, to "question the question." In this essay, evidence from published literature and clinical experience is presented, as well as a critical review of the first meta-analysis to explore this issue. The evidence presented supports the traditional view that PD dysphagia is responsive to levodopa.
authors: Pacific Neuroscience Medical Group, Oxnard, CA 93030, United States. james.sutton@pacificneuroscience.com
authors: James P
authors: JP
authors: Sutton
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D003679:Deglutition / Q000187:drug effects*; D003680:Deglutition Disorders / Q000188:drug therapy* / Q000209:etiology; D019317:Evidence-Based Medicine; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa